– Reuters
Raymond James Maintains Outperform on Veeva Systems, Lowers Price Target to $260
Raymond James analyst Brian Peterson maintains Veeva Systems (NYSE:VEEV) with a Outperform and lowers the price target from $335 to $260.
Related Posts
CORRECTION: Travere Therapeutics Q3 EPS $(0.13) Beats $(0.54) Estimate, Sales $68.22M Beat $60.93M Estimate
Travere Therapeutics (NASDAQ:TVTX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.54) by 75.93 percent. This is a 18.18 percent decrease over losses of $(0.11) per share
ANGI Homeservices Q3 EPS $(0.03) Beats $(0.07) Estimate, Sales $461.56M Beat $450.08M Estimate
ANGI Homeservices (NASDAQ:ANGI) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 400 percent decrease over earnings of $0.01 per share from
Deutsche Bank Maintains Buy on Agilon Health, Lowers Price Target to $30
Deutsche Bank analyst George Hill maintains Agilon Health (NYSE:AGL) with a Buy and lowers the price target from $36 to $30.